Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Growth From $1.46 Billion In 2026 To $2.86 Billion By 2030 At A CAGR Of 18.3%%
The market for neurorehabilitation exoskeletons powered by artificial intelligence has experienced rapid expansion in recent years. It is projected to increase from $1.24 billion in 2025 to $1.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.6%. This historical growth has been driven by factors such as the increasing prevalence of neurological disorders, the early integration of robotic rehabilitation technologies, improvements in sensor systems, a growing need for intensive therapy regimens, and the expansion of rehabilitation facilities.
The artificial intelligence-enhanced neurorehabilitation exoskeleton market is projected to experience substantial expansion in the coming years. By 2030, its value is anticipated to reach $2.87 billion, reflecting a compound annual growth rate (CAGR) of 18.3%. This forecasted growth is driven by factors such as AI-powered adaptive rehabilitation, the rise of home-based neurorehabilitation, a growing elderly population, increased reimbursement support for robotic therapy, and the integration of cloud-based analytics. Key trends shaping this period include personalized AI-driven rehabilitation programs, adaptive motion assistance systems, data-driven tracking of therapy outcomes, home-based robotic rehabilitation, and alignment with clinical rehabilitation protocols.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28918&type=smp
#Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Growth Drivers And Industry Catalysts
The increasing frequency of neurological conditions is anticipated to fuel expansion in the market for artificial intelligence (AI)-enhanced neurorehabilitation exoskeletons going forward. These disorders encompass medical issues affecting the brain, spinal cord, and nerves, resulting in difficulties with movement, cognition, sensation, or other bodily operations. The global uptick in such conditions is largely attributed to an aging population, since older individuals are more susceptible to illnesses like stroke, dementia, and Parkinson’s disease, whose prevalence climbs as age advances. AI-powered neurorehabilitation exoskeletons assist those with neurological disorders by offering customized, adaptable therapy that enhances motor abilities, speeds up recovery, and offsets impaired movement through constant monitoring and intelligent modifications tailored to each patient’s unique requirements. For example, in March 2023, the Alzheimer’s Association—a US-based nonprofit voluntary health organization—reported that roughly 6.7 million Americans aged 65 and older are currently affected by Alzheimer’s dementia, with projections indicating a rise to 13.8 million by 2060. Hence, the growing occurrence of neurological disorders is propelling the advancement of the AI-enhanced neurorehabilitation exoskeleton market.
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Categorization By Product Type And Application
The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Mobility Type: Mobile, Stationary
3) By Application: Stroke Rehabilitation, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis
4) By End-User: Hospitals And Clinics, Rehabilitation Centers, Home Care Settings
Subsegments:
1) By Hardware: Exoskeleton Frames, Actuators And Motors, Sensors And Wearable Devices, Control Units And Embedded Electronics
2) By Software: Motion Planning Software, Rehabilitation Protocol Software, Data Analytics And Monitoring Software, Connectivity And Integration Software
3) By Services: Implementation And Setup Services, Training And Education Services, Maintenance And Support Services, Remote Monitoring And Assistance Services
#Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Trends Influencing Long-Term Demand
Leading players in the AI-enhanced neurorehabilitation exoskeleton market are increasingly incorporating robotic control systems into their products to boost mobility, stability, and tailored therapy results. These robotic control systems, which oversee and coordinate exoskeleton movements, enable users to walk, stand, and carry out daily tasks with safety and efficiency by delivering accurate, stable, and adaptive motion. A case in point is in May 2025, when Wandercraft SAS, a robotics firm based in France, launched clinical trials in the United States for its AI-driven Personal Exoskeleton. This device merges advanced physical AI with robotic control systems, allowing individuals with spinal cord injuries, strokes, or other movement disorders to stand, walk, and traverse different terrains safely. By constantly adjusting to the user’s motions in real time, it improves mobility, stability, and rehabilitation progress. Featuring a joystick-operated control system paired with intelligent algorithms that predict shifts in weight, terrain, and speed, the exoskeleton fosters greater autonomy while lowering secondary health issues linked to extended wheelchair use.
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Company Landscape And Strategic Competition
Major companies operating in the artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market are Ottobock SE & Co. KGaA, Shanghai Fourier Intelligence Co. Ltd., Kinova Inc., Cyberdyne Inc., Hocoma AG, Myomo Inc., Neofect Co. Ltd., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., AlterG Inc., RENU ROBOTICS CORPORATION, ExoAtlet Global S.A., REEV Robotics, Bionik Laboratories Corp., Rex Bionics PLC, Wearable Robotics Srl, Gogoa Mobility Robots S.L., Technaid S.L., Bionic Yantra Pvt. Ltd., MediTouch Inc.
Access The Complete Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Report:
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Regional Analysis And Leading Geography
North America was the largest region in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market in 2025. The regions covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28918&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
